| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e13cf25eb1bef6199475314477618b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21c08c0f5b7157094b9165e9c2ec46f1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4711 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610f5fd68b05b7ea9613e45672a0f342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b771650a534ce50048f85f3f3c009769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a5db13900f3e9d36633bfa602c8b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347bc172b86745a8bcd930a8f789169a |
| publicationDate |
2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201138815-A |
| titleOfInvention |
Peptide vaccine |
| abstract |
Disclosed is a peptide which has a good immunogenicity and is capable of inducing an enhanced antibody productivity and additional administration of which can enhance the production of the target antibody. Specifically disclosed is a peptide comprising the amino acid sequence of a cell-binding motif of a cell adhesion molecule, an amino acid sequence (T) containing the amino acid sequence of a T cell epitope having an established immunological memory, an amino acid sequence (B) containing the amino acid sequence(s) of one or more specific B cell epitopes of an antigen, and the amino acid sequence of a linker peptide that is positioned between the aforesaid amino acid sequences (T) and (B) in such a manner as to link these amino acid sequences, characterized in that the amino acid sequence of said linker peptide is GKK, VKK or VVKK. Also disclosed are a medicinal composition which comprises the aforesaid peptide as the active ingredient and use of the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749674-A |
| priorityDate |
2010-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |